PTC (NASDAQ:PTC) Issues FY 2026 Earnings Guidance

PTC (NASDAQ:PTC) updated its FY 2026 earnings guidance on Friday. The company provided EPS guidance of 6.690-9.150 for the period, compared to the consensus EPS estimate of 7.250. The company issued revenue guidance of $2.7 billion-$2.9 billion, compared to the consensus revenue estimate of $2.8 billion.

PTC Stock Up 2.8%

PTC stock traded up $4.24 during midday trading on Friday, hitting $155.03. The stock had a trading volume of 264,988 shares, compared to its average volume of 1,120,256. The business has a fifty day moving average price of $168.13 and a 200 day moving average price of $188.30. PTC has a 12 month low of $133.38 and a 12 month high of $219.69. The stock has a market cap of $18.45 billion, a P/E ratio of 22.60, a P/E/G ratio of 2.54 and a beta of 1.03. The company has a current ratio of 1.22, a quick ratio of 1.22 and a debt-to-equity ratio of 0.31.

PTC (NASDAQ:PTC) last released its earnings results on Wednesday, February 4th. The technology company reported $1.92 EPS for the quarter, topping analysts’ consensus estimates of $1.59 by $0.33. The company had revenue of $685.83 million for the quarter, compared to the consensus estimate of $635.44 million. PTC had a return on equity of 24.63% and a net margin of 28.86%.PTC’s quarterly revenue was up 21.4% compared to the same quarter last year. During the same quarter last year, the business posted $1.10 EPS. PTC has set its Q2 2026 guidance at 1.930-2.540 EPS. Research analysts predict that PTC will post 4.46 EPS for the current year.

Analyst Ratings Changes

A number of equities analysts recently issued reports on the company. Rosenblatt Securities decreased their price objective on PTC from $220.00 to $200.00 and set a “buy” rating for the company in a report on Thursday, February 5th. Piper Sandler cut their price objective on shares of PTC from $200.00 to $175.00 and set a “neutral” rating on the stock in a research note on Friday, November 7th. BMO Capital Markets decreased their target price on shares of PTC from $219.00 to $189.00 and set an “outperform” rating for the company in a research report on Thursday, February 5th. Wall Street Zen cut shares of PTC from a “strong-buy” rating to a “buy” rating in a research note on Saturday, February 7th. Finally, Oppenheimer decreased their price objective on shares of PTC from $240.00 to $200.00 and set an “outperform” rating for the company in a report on Wednesday, January 28th. Eleven investment analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $188.08.

Insider Activity

In related news, EVP Staats Aaron C. Von sold 240 shares of the firm’s stock in a transaction that occurred on Wednesday, February 11th. The shares were sold at an average price of $161.10, for a total transaction of $38,664.00. Following the completion of the sale, the executive vice president directly owned 22,221 shares in the company, valued at approximately $3,579,803.10. This trade represents a 1.07% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, EVP Kristian Talvitie sold 50,291 shares of the company’s stock in a transaction that occurred on Tuesday, December 9th. The shares were sold at an average price of $173.14, for a total transaction of $8,707,383.74. Following the completion of the transaction, the executive vice president owned 12,386 shares in the company, valued at approximately $2,144,512.04. This represents a 80.24% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders sold 61,517 shares of company stock valued at $10,662,740. Company insiders own 0.29% of the company’s stock.

Key Headlines Impacting PTC

Here are the key news stories impacting PTC this week:

• Positive Sentiment: SPG Company selected PTC’s FlexPLM cloud PLM to replace legacy systems — a customer win that supports recurring SaaS/Cloud revenue growth and cross‑sell into retail PLM. This is a near‑term revenue and reference‑customer positive for PTC’s product lifecycle management business. PR: PTC FlexPLM SPG Company
• Neutral Sentiment: An executive (EVP Aaron Von Staats) sold 240 shares (~$38.7k) — disclosed in an SEC filing. The sale is small relative to his remaining stake and institutional ownership, so it’s unlikely to signal a material change in insider conviction. Insider trade report
• Neutral Sentiment: Investors are still digesting Q4 commentary — analysts’ “five analyst questions” summaries highlight areas management must show execution on (AI/product roadmap, margin leverage, subscription mix). These call takeaways can drive short‑term analyst sentiment but are informational rather than catalytic. Analyst Q&A summary
• Negative Sentiment: PTC issued FY‑2026 guidance that was mixed: EPS range of 6.690–9.150 vs. consensus ~7.25 (range includes the consensus but the low end is below) and revenue guidance $2.7–$2.9B vs. consensus ~$2.8B. The wide range increases uncertainty around margins and cadence of growth and likely explains some volatility as markets re‑rate forward expectations.
• Negative Sentiment: Several headlines circulating about “PTC” pulling a Duchenne therapy application (Translarna) refer to PTC Therapeutics (PTCT), a different company. Media/algorithmic headline noise may temporarily confuse investors and put directional pressure on PTC Inc. even though the biotech news is unrelated to PTC’s software business. Pharmaphorum: Translarna withdrawal (PTCT)

Hedge Funds Weigh In On PTC

Several institutional investors have recently bought and sold shares of PTC. Alyeska Investment Group L.P. boosted its stake in shares of PTC by 5.6% during the 4th quarter. Alyeska Investment Group L.P. now owns 169,102 shares of the technology company’s stock worth $29,459,000 after acquiring an additional 9,005 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its position in PTC by 2.2% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 926,425 shares of the technology company’s stock worth $161,392,000 after purchasing an additional 19,982 shares during the period. Van ECK Associates Corp boosted its position in PTC by 44.2% during the fourth quarter. Van ECK Associates Corp now owns 2,594 shares of the technology company’s stock worth $452,000 after purchasing an additional 795 shares during the period. State Street Corp grew its holdings in PTC by 5.6% during the fourth quarter. State Street Corp now owns 5,905,645 shares of the technology company’s stock valued at $1,028,822,000 after purchasing an additional 312,000 shares during the last quarter. Finally, Martingale Asset Management L P raised its position in shares of PTC by 90.9% in the fourth quarter. Martingale Asset Management L P now owns 3,575 shares of the technology company’s stock valued at $623,000 after purchasing an additional 1,702 shares during the period. 95.14% of the stock is currently owned by institutional investors.

About PTC

PTC Inc (NASDAQ: PTC) is a global technology company that develops software and services to help manufacturers design, operate, and service physical products. Founded in 1985 as Parametric Technology Corporation, PTC pioneered parametric, feature-based CAD with its Pro/ENGINEER product (now marketed as Creo) and has since expanded its portfolio to address product lifecycle management, Internet of Things (IoT), augmented reality (AR) and industrial connectivity.

Key product lines include Creo for 3D CAD; Windchill for product lifecycle management (PLM); ThingWorx, an IoT platform for connecting devices and building industrial applications; Vuforia, an AR platform for creating immersive service and training experiences; and Kepware, a suite for industrial connectivity and protocol translation.